Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Net Cash Flow (2018 - 2025)

TransMedics (TMDX) has 8 years of Net Cash Flow data on record, last reported at $22.1 million in Q4 2025.

  • For Q4 2025, Net Cash Flow rose 205.09% year-over-year to $22.1 million; the TTM value through Dec 2025 reached $150.4 million, up 361.07%, while the annual FY2025 figure was $150.4 million, 361.07% up from the prior year.
  • Net Cash Flow reached $22.1 million in Q4 2025 per TMDX's latest filing, down from $65.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $386.8 million in Q2 2023 and bottomed at -$155.2 million in Q3 2023.
  • Average Net Cash Flow over 5 years is $23.2 million, with a median of $503000.0 recorded in 2021.
  • Peak YoY movement for Net Cash Flow: surged 6821.28% in 2022, then crashed 772.79% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at $3.4 million in 2021, then tumbled by 210.18% to -$3.7 million in 2022, then plummeted by 772.79% to -$32.6 million in 2023, then skyrocketed by 122.22% to $7.2 million in 2024, then skyrocketed by 205.09% to $22.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $22.1 million in Q4 2025, $65.6 million in Q3 2025, and $89.6 million in Q2 2025.